Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
246.20
Dollar change
+2.58
Percentage change
1.06
%
IndexS&P 500 P/E58.23 EPS (ttm)4.23 Insider Own0.14% Shs Outstand290.39M Perf Week2.60%
Market Cap71.13B Forward P/E17.15 EPS next Y14.35 Insider Trans-1.15% Shs Float288.49M Perf Month4.96%
Income1.22B PEG6.73 EPS next Q2.97 Inst Own89.09% Short Float0.85% Perf Quarter4.25%
Sales19.49B P/S3.65 EPS this Y6.08% Inst Trans-1.90% Short Ratio1.47 Perf Half Y-11.14%
Book/sh87.68 P/B2.81 EPS next Y10.81% ROA2.47% Short Interest2.46M Perf Year2.41%
Cash/sh4.28 P/C57.55 EPS next 5Y8.65% ROE5.13% 52W Range228.62 - 287.32 Perf YTD0.97%
Dividend Est.3.74 (1.52%) P/FCF26.86 EPS past 5Y52.43% ROI3.09% 52W High-14.31% Beta0.44
Dividend TTM3.68 (1.49%) Quick Ratio0.64 Sales past 5Y4.18% Gross Margin41.37% 52W Low7.69% ATR (14)4.62
Dividend Ex-DateMar 07, 2024 Current Ratio1.08 EPS Y/Y TTM-21.92% Oper. Margin11.83% RSI (14)60.70 Volatility1.96% 1.98%
Employees73000 Debt/Eq0.64 Sales Y/Y TTM2.59% Profit Margin6.25% Recom1.69 Target Price277.58
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q-43.38% Payout73.72% Rel Volume0.59 Prev Close243.62
Sales Surprise-0.56% EPS Surprise11.66% Sales Q/Q2.62% EarningsFeb 01 BMO Avg Volume1.67M Price246.20
SMA202.70% SMA502.82% SMA200-2.93% Trades Volume992,660 Change1.06%
Date Action Analyst Rating Change Price Target Change
Jul-24-23Upgrade Raymond James Mkt Perform → Outperform $305
May-30-23Resumed Morgan Stanley Overweight $295
May-05-23Upgrade Piper Sandler Neutral → Overweight $260 → $290
Apr-12-23Upgrade KeyBanc Capital Markets Sector Weight → Overweight $304
Jan-03-23Upgrade BofA Securities Neutral → Buy $250 → $290
Dec-12-22Upgrade Citigroup Sell → Neutral $221 → $250
Jul-11-22Downgrade Citigroup Neutral → Sell $265 → $235
Jun-24-22Upgrade Wells Fargo Equal Weight → Overweight $275
Mar-18-22Resumed Raymond James Mkt Perform
Mar-02-22Resumed BofA Securities Neutral $290
Feb-23-24 11:14AM
Feb-21-24 06:45AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
Feb-13-24 12:07PM
04:43PM Loading…
Feb-12-24 04:43PM
Feb-06-24 10:28AM
Feb-05-24 12:23AM
Feb-02-24 08:52AM
12:17AM
12:01AM
Feb-01-24 01:11PM
10:35AM
10:01AM
09:30AM
07:40AM Loading…
07:40AM
07:20AM
07:03AM
06:36AM
06:30AM
Jan-31-24 11:52AM
Jan-30-24 06:45AM
Jan-29-24 10:49AM
09:16AM
Jan-25-24 10:29AM
10:00AM
06:45AM
Jan-23-24 04:15PM
06:45AM
Jan-10-24 06:45AM
04:15PM Loading…
Jan-05-24 04:15PM
Jan-04-24 04:15PM
Dec-22-23 07:00AM
Dec-14-23 03:06AM
Dec-12-23 07:00AM
Dec-11-23 06:55AM
Dec-08-23 02:15PM
06:17AM
Dec-07-23 09:08AM
07:17AM
07:01AM
06:50AM
Dec-06-23 05:09AM
Dec-05-23 02:18PM
Dec-04-23 04:15PM
05:10AM
Dec-01-23 04:10PM
Nov-30-23 06:27PM
01:04PM
06:50AM
Nov-22-23 12:13AM
Nov-21-23 06:50AM
Nov-14-23 04:15PM
Nov-12-23 11:42PM
Nov-10-23 02:31PM
02:31PM
01:39PM
12:01AM
Nov-09-23 05:21PM
04:58PM
02:05PM
01:17PM
11:17AM
10:51AM
09:30AM
07:56AM
07:05AM
06:52AM
06:30AM
06:25AM
Nov-06-23 12:12PM
09:48AM
Nov-02-23 10:00AM
06:50AM
Oct-25-23 04:15AM
Oct-23-23 06:32AM
Oct-20-23 02:41PM
Oct-18-23 01:08PM
Oct-17-23 08:46AM
Oct-16-23 04:35PM
Oct-12-23 04:15PM
Oct-11-23 09:12AM
Sep-26-23 08:00AM
Sep-25-23 09:47AM
Sep-19-23 11:50AM
11:25AM
Sep-08-23 01:19PM
Sep-07-23 08:00AM
07:02AM
Sep-06-23 11:38AM
Aug-30-23 12:26PM
Aug-23-23 04:15PM
Aug-13-23 04:24PM
Aug-11-23 07:00AM
05:59AM
Aug-09-23 09:48AM
Aug-05-23 09:00AM
Aug-03-23 11:50PM
12:57PM
09:30AM
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Garrison Michael DavidEVP & President MedicalDec 11Sale232.461,239288,0187,274Dec 12 04:31 PM
Byrd RichardEVP & President InterventionalNov 28Sale238.472,156514,1414,120Nov 29 07:27 PM
Goette RolandEVP and President, EMEANov 16Option Exercise107.123,544379,63317,164Nov 20 02:20 PM
Byrd RichardEVP & President InterventionalSep 05Sale274.48459125,9863,444Sep 06 09:32 AM
Fraser ClaireDirectorAug 28Sale281.66848238,84821,608Aug 30 08:48 AM
Hickey DavidEVP & President, Life SciencesAug 11Option Exercise132.543,883514,6539,030Aug 14 04:40 PM
Hickey DavidEVP & President, Life SciencesAug 11Sale277.852,974826,3264,199Aug 14 04:40 PM
Garrison Michael DavidEVP & President MedicalAug 08Sale277.131,300360,2695,157Aug 09 02:41 PM